Special Report
In a humiliating backdown, 39 of the world’s pharmaceutical companies dropped  their lawsuits against South Africa, which will allow Pretoria to buy anti-AIDS medicines at generic drug prices.

And the ramifications go far beyond South Africa’s borders and the cheap treatments needed for people with HIV/AIDS. By withdrawing their objections to South African legislation in the face of enormous international pressures and adverse publicity, the way is now open for other developing countries to enact similar laws.. ...Full story